Picture Demy-Colton BioFuture 2023 NYC InPerson Virtually 650x200px

News > All

Total search results: 7354 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 72 73 74  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Bicycle Therapeutics plc. (5/4/23). "Press Release: Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets". Cambridge & Boston, 2023-05-04
Magenta Therapeutics, Inc.. (5/3/23). "Press Release: Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement". Cambridge, MA. 2023-05-03
Qiagen N.V.. (5/3/23). "Press Release: Qiagen Exceeds Outlook for Q1 2023 with 12% CER Sales Growth in Non-COVID Product Portfolio". Venlo. 2023-05-03
MorphoSys AG. (5/3/23). "Press Release: MorphoSys AG Reports First Quarter 2023 Financial Results". Planegg. 2023-05-03
Immatics N.V.. (5/2/23). "Press Release: Immatics Reports Interim Clinical Data from Ongoing Phase 1b Cohort A Monotherapy with ACTengine IMA203 TCR-T Targeting PRAME". Houston, TX & Tübingen. 2023-05-02
LifeArc. (5/2/23). "Press Release: Dr Jason Slingsby Joins LifeArc as Chief Business Officer". 2023-05-02
MicrofluidX Ltd.. (5/2/23). "Press Release: MicrofluidX and Immatics Working Together on Automated End-to-End Bioprocessing for TCR-T Therapies". Stevenage & Houston, TX. 2023-05-02
Memo Therapeutics AG. (5/2/23). "Press Release: Memo Therapeutics AG Receives FDA Fast Track Designation for AntiBKV as Treatment of BKV Infection in Renal Transplant Patients". Schlieren. 2023-05-02
Anavo Therapeutics B.V.. (5/2/23). "Press Release: Anavo Therapeutics Extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic". Leiden & Heidelberg. 2023-05-02
Immatics N.V.. (5/1/23). "Press Release: Immatics Announces First Bristol Myers Squibb Opt-in of TCR-T Candidate from Ongoing Multi-target Strategic Collaboration". Tübingen & Houston, TX. 2023-05-01
Evommune, Inc.. (4/26/23). "Press Release: Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases". Palo Alto, CA. 2023-04-26
ImmunOs Therapeutics AG. (4/25/23). "Press Release: ImmunOs Therapeutics Appoints Michael A. Curran, PhD, as Chairman of its Scientific Advisory Board". Schlieren & Gaithersburg, MD. 2023-04-25
Ginkgo Bioworks Inc.. (4/24/23). "Press Release: Visolis and Ginkgo Bioworks Announce Partnership to Improve Microbial Strain for Bio-Isoprene and Sustainable Aviation Fuel Production". Hayward, CA & Boston, MA. 2023-04-24
3B Pharmaceuticals GmbH. (4/24/23). "Press Release: 3B Pharmaceuticals Enters into a Global Exclusive Licensing Agreement for its FAP-Targeting Peptide Technology". Berlin. 2023-04-24
Tubulis GmbH. (4/20/23). "Press Release: Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients". Munich. 2023-04-20
Lifespin GmbH. (4/20/23). "Press Release: Lifespin Announces Inaugural Membership in the Industrial Participant Program of the Wyss Diagnostics Accelerator at Harvard University". Regensburg & Boston, MA. 2023-04-20
Forbion Capital Partners. (4/19/23). "Press Release: Forbion Raises €1.35 Billion across Two Funds". Espoo. 2023-04-19
VectivBio Holding AG. (4/19/23). "Press Release: VectivBio Reports Full Year 2022 Financial Results and Provides Business Update". Basel. 2023-04-19
Gilde Healthcare Partners. (4/19/23). "Press Release: Gilde Healthcare Raises €600 Million to Invest in Healthcare innovation". Utrecht. 2023-04-19
Complement Therapeutics GmbH. (4/17/23). "Press Release: Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases". Munich. 2023-04-17
Pieris Pharmaceuticals, Inc.. (4/17/23). "Press Release: Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa (PRS-343) At 2023 AACR Annual Meeting". Boston, MA. 2023-04-17
Lunaphore Technologies S.A.. (4/17/23). "Press Release: Bio-Techne and Lunaphore Establish Strategic Partnership to Develop the First Fully Automated Same-slide Spatial Multiomics Solution". Minneapolis, MN & Lausanne. 2023-04-17
Argenx SE. (4/17/23). "Press Release: Argenx and Genmab Enter Partnership to Advance Antibody Therapies in Immunology and Oncology". Amsterdam. 2023-04-17
Ginkgo Bioworks Inc.. (4/17/23). "Press Release: Ginkgo Bioworks and Syngenta Seeds Announce Collaboration to Develop New Traits for the Next Generation of Seed Technology". Boston, MA. 2023-04-17
ITM Isotope Technologies Munich SE. (4/17/23). "Press Release: ITM Appoints Roger Estafanos as U.S. General Manager and Expands Presence with Opening of U.S. Headquarters in Princeton, New Jersey". Garching & Princeton, NJ. 2023-04-17
Merck & Co., Inc.. (4/16/23). "Press Release: Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.". Rahway, NJ & San Diego, CA. 2023-04-16
CellPhenomics GmbH. (4/14/23). "Press Release: CELLphenomics’ and Kyan Therapeutics Combined Platforms Provide Best-in-Class Solutions to Support the Biopharma Industry". Berlin & Singapore. 2023-04-14
CRISPR Therapeutics AG. (4/13/23). "Press Release: CRISPR Therapeutics to Participate in Needham’s 22nd Annual Healthcare Conference". Zug & Cambridge, MA. 2023-04-13
Alentis Therapeutics AG. (4/13/23). "Press Release: Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1". Basel. 2023-04-13
TORL BioTherapeutics LLC. (4/13/23). "Press Release: TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics". Los Angeles, CA. 2023-04-13
Agilent Technologies Inc.. (4/12/23). "Press Release: Agilent and PathAI Partner to Deliver AI-Powered Assay Development Solutions for Biopharma Research and Clinical Applications". Santa Clara, CA. 2023-04-12
InflaRx N.V.. (4/11/23). "Press Release: InflaRx Announces Public Offering of Ordinary Shares". Jena. 2023-04-11
InflaRx N.V.. (4/11/23). "Press Release: InflaRx Announces Pricing of $40 Million Public Offering of Ordinary Shares". Jena. 2023-04-11
AlphaSense Inc.. (4/11/23). "Press Release: AlphaSense Raises $100M Led By Alphabet's CapitalG to Fuel Innovation in AI and Market Intelligence". New York, NY. 2023-04-11
Biocartis Group N.V.. (4/11/23). "Press Release: Biocartis Appoints Roger Moody as New CEO". Mechelen. 2023-04-11
Calida Therapeutics S.A.S.. (4/6/23). "Press Release: French Biotech Calida Therapeutics Launches with Seed Funding, Leveraging US Academic Research in Thrombo-inflammatory Disorders". Paris. 2023-04-06
Proxygen GmbH. (4/5/23). "Press Release: Proxygen Announces Collaboration and License Agreement with MSD". Vienna. 2023-04-05
Synthego Corporation. (4/5/23). "Press Release: Synthego Launches Express Cell Pools for Faster, More Efficient Genome Editing". Redwood City, CA. 2023-04-05
Adcendo ApS. (4/4/23). "Press Release: Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline". Copenhagen. 2023-04-04
Mithra Pharmaceuticals S.A.. (4/4/23). "Press Release: Mithra Announces the Appointment of David H Solomon as Chief Executive Officer". Liège. 2023-04-04
AiCuris Anti-infective Cures AG. (4/4/23). "Press Release: AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary". Cambridge. 2023-04-04
Ginkgo Bioworks Inc.. (4/4/23). "Press Release: Solvay Announces Strategic Collaboration with Ginkgo Bioworks and Expands Its R&I Footprint in the United States". Brussels & Boston, MA. 2023-04-04
Scorpion Therapeutics, Inc.. (4/4/23). "Press Release: Scorpion Therapeutics and Pierre Fabre Announce Collaboration and License Agreement to Co-Develop and Commercialize STX-721 and STX-241 for Patients with EGFR Mutant Non-Small Cell Lung Cancer". Bost 2023-04-04
Cure Ventures. (4/4/23). "Press Release: Cure Ventures Launches with the Close of Inaugural $350 Million Fund". Boston, MA. 2023-04-04
InflaRx N.V.. (4/4/23). "Press Release: InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients". Jena. 2023-04-04
AMSilk GmbH. (4/4/23). "Press Release: AMSilk Announces Extension of Series C Financing to EUR 54M". Munich. 2023-04-04
BioNTech SE. (4/3/23). "Press Release: BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors". Mainz & Shanghai. 2023-04-03
PolyPeptide Group AG. (4/3/23). "Press Release: PolyPeptide Appoints Juan-José Gonzalez as CEO and Announces Change of CFO". Baar. 2023-04-03
Illumina, Inc.. (4/3/23). "Press Release: Illumina Will Appeal FTC Decision in Federal Court, Will Seek US Resolution by Late 2023 or Early 2024". San Diego, CA. 2023-04-03
Endpoints Company. (4/3/23). "Press Release: Financial Times Acquires Majority Stake in Endpoints News". Lawrence, KS. 2023-04-03
CRISPR Therapeutics AG. (4/3/23). "Press Release: CRISPR Therapeutics and Vertex Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for Exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalas 2023-04-03
Sartorius. (3/31/23). "Press Release: Sartorius to Acquire Polyplus. France-based Polyplus Is a Provider of Innovative Upstream Technologies for Cell and Gene Therapies". Göttingen. 2023-03-31
EQT AB. (3/29/23). "Press Release: EQT Life Sciences Closes Dementia Fund at the Hard Cap". 2023-03-29
CRISPR Therapeutics AG. (3/29/23). "Press Release: CRISPR Therapeutics Announces Departure of Board Member". Zug & Boston, MA. 2023-03-29
InfanDx AG. (3/28/23). "Press Release: InfanDx AG Revises Strategy and Broadens Diagnostics Pipeline for Child Health". Cologne, Berlin & Boston, MA. 2023-03-28
Bicycle Therapeutics plc. (3/28/23). "Press Release: Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates". Cambridge & Boston, MA. 2023-03-28
CRISPR Therapeutics AG. (3/27/23). "Press Release: CRISPR Therapeutics and Vertex Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes". Boston, MA & Zug. 2023-03-27
SR One Capital Management. (3/27/23). "Press Release: SR One Closes Second Venture Fund at $600M". Redwood City, CA & London. 2023-03-27
ABL Biomanufacutring. (3/27/23). "Press Release: ABL Appoints Stéphanie Colloud as General Manager and Chief Operating Officer to Lead European Activities". Lyon. 2023-03-27
Secarna Pharmaceuticals GmbH & Co. KG. (3/27/23). "Press Release: Secarna Pharmaceuticals and SciNeuro Pharmaceuticals Enter into Research and Option Agreement in the Field of CNS Diseases". Martinsried. 2023-03-27
Endpoints Company. (3/27/23). "Press Release: Endpoints News Announces New Editorial Hires in Coverage Expansion". Lawrence, KS. 2023-03-27
Lunaphore Technologies S.A.. (3/23/23). "Press Release: Lunaphore Raises CHF40M in the First Close of Series D Funding Led by EGS Beteiligungen AG". Lausanne. 2023-03-23
Endpoints Company. (3/23/23). "Press Release: Endpoints News Appoints Ryan McRae as Chief Revenue Officer". Lawrence, KS. 2023-03-23
Collaborative Drug Discovery, Inc.. (2/23/23). "Press Release: German Drug Development Company Prosion Therapeutics Selects CDD Vault to Host Its R&D Data". Cologne & San Francisco, CA. 2023-03-23
Agilent Technologies Inc.. (3/22/23). "Press Release: Agilent Honored with Asia Pacific Bioprocessing Excellence Award 2023 for Analytical Services". Singapore. 2023-03-22
Roche. (3/22/23). "Press Release: Roche Announces Collaboration with Lilly to Enhance Early Diagnosis of Alzheimer's Disease". Basel. 2023-03-22
Berkeley Lights, Inc.. (3/21/23). "Press Release: Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company". Emeryville, CA. 2023-03-21
Vitestro. (3/21/23). "Press Release: Vitestro Raises EUR 12 Million in Series A Financing Round to Bring the World's First Autonomous Blood Drawing Device to the European Market". Utrecht. 2023-03-21
BioNTech AG. (3/20/23). "Press Release: BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications". Mainz & Rockville, MD. 2023-03-20
Pear Therapeutics, Inc.. (3/17/23). "Press Release: Pear Therapeutics Announces Process Exploring Strategic Alternatives". Boston, MA. 2023-03-17
Pear Therapeutics, Inc.. (3/17/23). "Press Release: Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process". Boston, MA. 2023-03-17
Scailyte AG. (3/16/23). "Press Release: Scailyte Announces Collaboration with Turnstone Biologics". Basel. 2023-03-16
Biovian Oy. (3/16/23). "Press Release: Remedium Bio and Biovian Have Agreed to Collaborate on Remedium’s First-in-Class Disease Modifying AAV Gene Therapy for Osteoarthritis". 2023-03-16
Seamless Therapeutics GmbH. (3/16/23). "Press Release: Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases". Dresden. 2023-03-16
Synthego Corporation. (3/16/23). "Press Release: Synthego Introduces CRISPR Discovery Partners to Streamline CRISPR-Driven Drug Discovery Research". Redwood City, CA. 2023-03-16
Aldena Therapeutics Inc.. (3/16/23). "Press Release: Aldena Therapeutics Accelerates Its Novel and Disruptive Approach to Immuno-Dermatology". Boston, MA. 2023-03-16
Patient Square Capital L.P.. (3/16/23). "Press Release: Patient Square Capital Partners with Health Care Veteran John Marotta to Focus on Life Science Tools and Diagnostics Opportunities". Menlo Park, CA. 2023-03-16
Proxygen GmbH. (3/15/23). "Press Release: Proxygen Announces Formation of Board of Directors". Vienna. 2023-03-15
Owlstone Medical Ltd.. (3/15/23). "Press Release: Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection". Cambridge. 2023-03-15
Mediar Therapeutics Inc.. (3/15/23). "Press Release: Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies". Cambridge, MA. 2023-03-15
Lys Therapeutics S.A.S.. (3/15/23). "Press Release: Lys Therapeutics Secures Funding from The Michael J. Fox Foundation to Accelerate the Development of Its Drug Candidate in Parkinson’s Disease". Lyon & Caen. 2023-03-15
UCB S.A.. (3/15/23). "Press Release: Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease". Brussels & Somerville, MA. 2023-03-15
CN Bio Innovations Ltd.. (3/14/23). "Press Release: CN Bio Appoints Deepak Singh as Vice President of Sales and Marketing". Cambridge. 2023-03-14
BioNTech AG. (3/14/23). "Press Release: Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years". New York & Mainz. 2023-03-14
Bayer AG. (3/14/23). "Press Release: Bayer Collaborates with Microsoft to Unveil New Cloud-based Enterprise Solutions, advancing innovation and transparency in the agri-food industry". San Francisco, CA. 2023-03-14
MorphoSys AG. (3/14/23). "Press Release: Lucinda Crabtree to Join MorphoSys as Chief Financial Officer". Planegg. 2023-03-14
Exscientia plc. (3/14/23). "Press Release: Exscientia Announces Expansion of its Precision Oncology Pipeline". Oxford. 2023-03-14
Bayer AG. (3/14/23). "Press Release: BlueRock Therapeutics to Incorporate Wearable and Invisible Contactless Digital Health Technologies from Rune Labs and Emerald Innovations in Parkinson’s Disease Clinical Trial". Cambridge. 2023-03-14
Sanofi S.A.. (3/13/23). "Press Release: Sanofi to Acquire Provention Bio, Adding to Portfolio TZIELD, the First Disease-modifying Treatment for the Delay of Stage 3 Type 1 Diabetes (T1D)". Paris & Red Bank, NJ. 2023-03-13
Seagen Inc.. (3/13/23). "Press Release: Pfizer Invests $43 Billion to Battle Cancer. Pfizer to Acquire Seagen for $229 per Seagen Share in Cash". New York, NY & Bothell, WA. 2023-03-13
CRISPR Therapeutics AG. (3/13/23). "Press Release: CRISPR Therapeutics Announces Transition of Chief Financial Officer". Zug & Boston, MA. 2023-03-13
Agilent Technologies Inc.. (3/10/23). "Press Release: Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu". Santa Clara, CA. 2023-03-10
UCB S.A.. (3/9/23). "Press Release: UCB’s Board of Directors Appoints Jonathan Peacock as New Chair". Brussels. 2023-03-09
Bayer AG. (3/9/23). "Press Release: AskBio Announces Gustavo Pesquin as New CEO". Research Triangle Park, NC. 2023-03-09
Iktos S.A.S.. (3/9/23). "Press Release: Iktos Raises € 15.5m Series A Round to Expand Its Artificial Intelligence-based Drug Discovery Technologies and Solutions". Paris & Lausanne. 2023-03-09
Agilent Technologies Inc.. (3/9/23). "Press Release: Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development". Santa Clara, CA. 2023-03-09
Agilent Technologies Inc.. (3/8/23). "Press Release: Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine". Santa Clara, CA. 2023-03-08
Cellbox Solutions GmbH. (3/7/23). "Press Release: Cellbox Solutions Raises EUR 6.5 Million in Series A1 Financing Round". Norderstedt. 2023-03-07
Noema Pharma AG. (3/7/23). "Press Release: Noema Pharma Raises CHF 103 million (USD 112 million) in Series B Financing Round Led by Forbion and Jeito Capital". Basel. 2023-03-07
Personalis, Inc.. (3/7/23). "Press Release: Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay". Fremont, CA. 2023-03-07
next pagenext page 1 2 3 4 ... 72 73 74  next pagenext page


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2023 NYC Industry Leaders 650x300px

» top